Karuna Therapeutics, Inc. (KRTX)
Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.
Address
99 HIGH STREET
BOSTON, MA 02110
Founded
2009
Number of Employees
339
Website
http://www.karunatx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)